Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00451354
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 2BJS | 0.7 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1QJE | 0.7 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BK0 | 0.7 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BLZ | 0.7 | |
PYH | N~6~-{[(2R,3R)-3-METHYL-3,4-DIHYDRO- 2H-PYRROL-2-YL]CARBONYL}-L-LYSINE | A | 2ZCE | 0.7 | |
DIQ | 2-METHYL-DECAHYDRO-ISOQUINOLINE- 3-CARBOXYLIC ACID | A,B | 1HXB | 0.72 | |
DIQ | 2-METHYL-DECAHYDRO-ISOQUINOLINE- 3-CARBOXYLIC ACID | A,B | 2FGU | 0.72 | |
DIQ | 2-METHYL-DECAHYDRO-ISOQUINOLINE- 3-CARBOXYLIC ACID | A,B | 2FGV | 0.72 | |
DIQ | 2-METHYL-DECAHYDRO-ISOQUINOLINE- 3-CARBOXYLIC ACID | A,B | 1MTB | 0.72 | |
CYJ | (Z)-N~6~-[(4R,5S)-5-(2-CARBOXYETHYL)- 4-(CARBOXYMETHYL)PIPERIDIN-3-YLIDENE]- L-LYSINE | A,B | 2C14 | 0.74 | |
O12 | N~5~-dodecanoyl-L-ornithine | A,B,C,D,E,F, G,H,I,J,K,L | 3CAY | 0.72 | |
O12 | N~5~-dodecanoyl-L-ornithine | A,B,C,D,E,F, G,H,I,J,K,L | 3CBA | 0.72 | |
DLS | DI-ACETYL-LYSINE | A,B,C,D,E,F | 1FVM | 0.71 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B | 2J9P | 0.75 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B,C,D | 2VGK | 0.75 | |
REY | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANINE | A | 1IKI | 0.78 | |
BB2 | ACTINONIN | A,B,C,D | 3G5K | 0.7 | |
BB2 | ACTINONIN | A,B,C | 1LRU | 0.7 | |
BB2 | ACTINONIN | A,B | 2OKL | 0.7 | |
BB2 | ACTINONIN | A | 2OS1 | 0.7 | |
BB2 | ACTINONIN | A,B,C | 1G2A | 0.7 | |
BB2 | ACTINONIN | A | 1Q1Y | 0.7 | |
BB2 | ACTINONIN | A,B,C,D,E,F, G,H | 1SZZ | 0.7 | |
BB2 | ACTINONIN | A | 1LQY | 0.7 | |
BB2 | ACTINONIN | A | 2OS3 | 0.7 | |
BB2 | ACTINONIN | A | 1LRY | 0.7 | |
BB2 | ACTINONIN | A,B | 1IX1 | 0.7 | |
BB2 | ACTINONIN | A | 1WS1 | 0.7 | |
IGN | {[(1R)-2-((2S)-2-{[(3-{[AMINO(IMINO)METHYL]AMINO}PROPYL)AMINO]CARBONYL}PIPERIDINYL)- 1-(CYCLOHEXYLMETHYL)-2-OXOETHYL]AMINO}ACETIC ACID | A | 1K1O | 0.76 | |
IGN | {[(1R)-2-((2S)-2-{[(3-{[AMINO(IMINO)METHYL]AMINO}PROPYL)AMINO]CARBONYL}PIPERIDINYL)- 1-(CYCLOHEXYLMETHYL)-2-OXOETHYL]AMINO}ACETIC ACID | H,I | 1K21 | 0.76 | |
DAA | 8-AMINO-7-CARBOXYAMINO-NONANOIC ACID WITH ALUMINUM FLUORIDE | A | 1BS1 | 0.73 | |
MCP | 2-CARBOXY-4-METHYLPIPERIDINE | H | 1ETR | 0.71 | |
BUJ | (3R)-3-(hexadecanoylamino)-4-(trimethylammonio)butanoate | A,B | 2RCU | 0.72 | |
NC7 | 7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID | A | 1ZD5 | 0.7 | |
AR9 | (2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7- dimethyl-3,15-dioxo-1,4-diazacyclopentadecan- 5-yl]-4-hydroxy-2-methylbutanamide | A,B,C | 3DV1 | 0.73 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2B4D | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD9 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVR | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVS | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVQ | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OT7 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2B5G | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 2GIV | 0.72 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNY | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 1JSP | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,I,L | 2V5W | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,D | 3D4B | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OQ6 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R0Y | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 3CZ7 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 1JM4 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H4H | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2J6V | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R10 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1YC5 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OX0 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2G | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,D | 2H4F | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 2OU2 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1S5P | 0.72 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNW | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 3D35 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD2 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 2ZFN | 0.72 | |
ALY | N(6)-ACETYLLYSINE | C,D | 2C1J | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQG | 0.72 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNX | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1MA3 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2H | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 2I2Z | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD7 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | P | 1E6I | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZC | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D,I,J, K,L | 3EWF | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2D | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1Q1A | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZD | 0.72 | |
ALY | N(6)-ACETYLLYSINE | Q,R | 2E3K | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 2OZU | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQF | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C | 2R0V | 0.72 | |
REX | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANYL-D-ALANINE | A | 1IKG | 0.77 | |
DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A | 1DAG | 0.75 | |
DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A | 1DAF | 0.75 | |
DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A,B,C,D | 3FMF | 0.75 | |
DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A | 1DAI | 0.75 | |
LY5 | (3S,4aR,6S,8aR)-6-{[(2S)-2-carboxy- 4,4-difluoropyrrolidin-1-yl]methyl}decahydroisoquinoline- 3-carboxylic acid | A,B,C,D | 2QS4 | 0.71 | |
UZ9 | (2S)-2-AMINO-6-({(4R)-4-[(10R,13S)- 10,13-DIMETHYL-3-OXOHEXADECAHYDRO- 1H-CYCLOPENTA[A]PHENANTHREN-17- YL]PENTANOYL}AMINO)HEXANOIC ACID | A,B | 1UZ9 | 0.73 | |
U17 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXYHEPTANOYL]- L-SERYL-L-LEUCINATE | A | 2GGB | 0.71 | |
S80 | N1-HYDROXY-2-(3-HYDROXY-PROPYL)- 3-ISOBUTYL-N4-[1-(2-METHOXY-ETHYL)- 2-OXO-AZEPAN-3-YL]-SUCCINAMIDE | A,B | 1BIW | 0.7 | |
ITL | (3alpha,5alpha,8alpha)-3-[(N,N- bis{2-[bis(carboxymethyl)amino]ethyl}- L-gamma-glutamyl)amino]cholan-24- oic acid | A | 2K62 | 0.74 | |
IVS | 3-HYDROXY-6-METHYL-4-(3-METHYL- 2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER | A,B | 1ME6 | 0.74 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.73 |